Related Experiment Video

Updated: Jun 13, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

First CD123-targeted ADC secures FDA approval for rare blood cancer

Asher Mullard

    Nature Reviews. Drug Discovery
    |June 11, 2026
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Isolation of CD133+ Liver Stem Cells for Clonal Expansion
    12:06

    Isolation of CD133+ Liver Stem Cells for Clonal Expansion

    Published on: October 10, 2011

    Related Experiment Videos

    Last Updated: Jun 13, 2026

    A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
    08:46

    A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

    Published on: November 12, 2019

    Isolation of CD133+ Liver Stem Cells for Clonal Expansion
    12:06

    Isolation of CD133+ Liver Stem Cells for Clonal Expansion

    Published on: October 10, 2011

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Strengthening muscle for healthy ageing: innovative treatments for sarcopenia.

    Nature reviews. Drug discovery·2026

    Solute carrier membrane transporters: emerging targets in CNS disorders.

    Nature reviews. Drug discovery·2026

    Towards precision psychiatry: initial foundations and future directions.

    Nature reviews. Drug discovery·2026

    Targeting CDKs in the RNAPII transcription cycle.

    Nature reviews. Drug discovery·2026

    Artificial intelligence in drug discovery - what it is, where we stand and the path forward.

    Nature reviews. Drug discovery·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us